Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 20.19M P/E - EPS this Y 69.90% Ern Qtrly Grth -
Income -38.76M Forward P/E 6.87 EPS next Y 148.00% 50D Avg Chg -7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -44.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -82.00%
Recommedations 2.50 Quick Ratio 0.04 Shares Outstanding 24.46M 52W Low Chg 27.00%
Insider Own 13.78% ROA -65.27% Shares Float 18.37M Beta 0.44
Inst Own 29.91% ROE - Shares Shorted/Prior 493.55K/898.08K Price 0.82
Gross Margin - Profit Margin - Avg. Volume 169,687 Target Price 1.50
Oper. Margin - Earnings Date Mar 25 Volume 188,362 Change -2.83%
About Acer Therapeutics Inc.

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company's pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-801 for the treatment of induced Vasomotor Symptoms, post-traumatic stress disorder, and prostate cancer; and OLPRUVA, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. It has a license agreement with Sanofi to acquire worldwide rights to Osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist; an option agreement with Relief for the development, regulatory approval, and commercialization of OLPRUVA; and an agreement with Emory University to acquire the worldwide intellectual property rights to a family of patents and patent applications related to the use of neurokinin receptor antagonists in managing conditioned fear and treating anxiety disorders, including post-traumatic stress disorder. The company was incorporated in 1991 and is headquartered in Newton, Massachusetts. As of November 17, 2023, Acer Therapeutics Inc. operates as a subsidiary of Zevra Therapeutics, Inc.

ACER Chatroom

User Image flybyme Posted - 04/29/24

$ACER

User Image enezyfm Posted - 04/28/24

$ACER Gentlemen let's acer management's explaining contingent value ✅️ Rights (CVRs). Waiting for answers Regards

User Image _nic Posted - 04/08/24

@Joesh82 hcw is worth shit $NRXP $RLFTF $ACER

User Image enezyfm Posted - 04/07/24

$ACER What about ACER VCRs!!!!

User Image enezyfm Posted - 04/07/24

$ACER

User Image enezyfm Posted - 04/04/24

$ACER

User Image enezyfm Posted - 03/27/24

$ACER

User Image enezyfm Posted - 03/26/24

$ACER

User Image enezyfm Posted - 03/23/24

$ACER Dear ACER shareholders Please now our concern and focus on ACER CVRs only. Everybody must fighting and fighting till we receive our acer CVRs. Now....its a message to acer management and zvra management...if you forget or hidden our acer theraputics cvrs ..... I can't write what will happen. I challenge It's our money It's our money It's our money We didn't cheating anybody... But...but...but you cheating us...you will see the result soon. Enough.

User Image enezyfm Posted - 03/22/24

$ACER 👋

User Image saleh1010 Posted - 03/14/24

$ACER merger is complete what’s next where is our money

User Image enezyfm Posted - 03/11/24

$ACER acer stockholders...we want latest news.

User Image salemsliman Posted - 2 months ago

$ACER $ZVRA Where is the rest of the money we promised to get from the acquisition?

User Image enezyfm Posted - 02/29/24

$ACER Any updating Pleaseeeeee

User Image enezyfm Posted - 02/29/24

$ACER anyabdating February 2024 gone...

User Image flybyme Posted - 02/20/24

$ACER Zevar shares are doing ok , a steady climb.

User Image Jon752 Posted - 02/15/24

$acer $ZVRA Schwab and Etrade are reporting the sale two different ways on the 1099. Etrade is showing it as a sale of Acer stock and a purchase of Zevra (which aligns with the prospectus). Schwab does not show the transaction on the 1099. I don't really care which way it is reported, I just don't want to give the IRS a reason to question my returns.

User Image enezyfm Posted - 02/14/24

$ACER Any updates.

User Image Jon752 Posted - 02/12/24

$ACER $ZVRA Until I received my 1099, I didn't realize that the buyout of acer by zvra was a taxable event.

User Image WaynD01 Posted - 02/09/24

$ZVRA I expect an $ARDX like move once 1) $ACER acquisition related loose shares are flushed out 2) Close to Adcom ( if not by Q4 ER call in Early March) Or May be, 3) Oppenheimer conference next week open the flood gate

User Image enezyfm Posted - 02/05/24

$ACER Question to the Expert How Many CVRs will Received ? Thanks.

User Image salemsliman Posted - 02/05/24

$ACER ANY NEW NEWS TODAY 🥺🥺🥺

User Image saleh1010 Posted - 01/23/24

$ACER all of us waiting the cvr I thing in the end of February they finish merg

User Image enezyfm Posted - 01/21/24

$ACER I want to ask you question. How many persons 🤔 like me waiting ACER CVRs ? Acer theraputics stockholders Please give me feedback. 😊

User Image suburbanfarmer Posted - 01/19/24

@SIXswiss But $ACER doesn't exist anymore...

User Image enezyfm Posted - 01/17/24

$ACER why like this I try to write CVRS. What's wrong.

User Image SIXswiss Posted - 01/10/24

$ACER all the way. Do your dooooo dooo due diligence and figure out the plays here

User Image coastalstocks81 Posted - 01/04/24

$ACER next big runner runner? i feel she is wanting it

User Image DataJim Posted - 12/26/23

$ORPH $ACER it’s been a rough go but if you still have a stomach for clinical stage bio check out $NGENF https://blinkofaneye.org/blinkofaneyepodcast/ Episode 194 42:13 (interviewer) Another one of our families who’s been involved, they don’t know if they have placebo or if the real peptide but they’ve been thrilled by the hour they’ve had every day, by the assessments, what they’re learning about their son’s body AND there has already been improvement and it was only days then … 42:43 (Meghan at Shirley Ryan) It’s exciting because we all it’s a double blinded trial so no one knows anything except the pharmacist because the placebo you constitute the same way and it all looks the same but I will say obviously there’s speculation when we see individuals making gains and we get really excited and we want to know is it the drug, is it the placebo effect but is it the drug so it’s just - it’s worth it …

User Image Pg69 Posted - 12/25/23

$ACER pharmaceutical sonoma An acquired report estimates the new pulse treatment at 290 dollars with a projection of nearly 100,000 patients in the US and it means quadrupling turnover in 2024 great news boommm

Analyst Ratings
HC Wainwright & Co. Neutral Sep 5, 23
Roth Capital Neutral Sep 1, 23
Roth MKM Neutral Sep 1, 23
HC Wainwright & Co. Buy Mar 28, 23
EF Hutton Buy Mar 20, 23
EF Hutton Buy Feb 2, 22
Needham Hold Jun 25, 19
Wedbush Outperform May 23, 19
Needham Buy Dec 20, 18